Christos Volikákis, a Greek track sprinter, has received a three-year racing ban following a positive test for Ligandrol (LGD-4033), an experimental performance-enhancing drug. His sample, taken during the 2016 Rio Olympics, was retested, confirming the presence of this selective androgen receptor modulator. The Union Cycliste Internationale (UCI) announced the sanction, which applies retroactively, with his ineligibility extending until 2027. Having previously competed in three Olympic Games without medaling, Volikákis did win 17 national titles across various track disciplines.
The Union Cycliste Internationale (UCI) announces that the Greek rider Christos Volikákis has been sanctioned with a period of ineligibility of three years following an Anti-Doping Rule Violation (ADRV) for the presence of Selective Androgen Receptor Modulators (SARMs) of LGD-4033 metabolite.
The retest of Volikákis' sample showed the presence of Ligandol, an experimental drug which falls under the Selective Androgen Receptor Modulators (SARMs) class of drugs, providing the same benefits as anabolic steroids without the side effects on reproductive organs.
Collection
[
|
...
]